CELYAD ONCOLOGY SA Profit Loss From Continuing Operations
CELYAD ONCOLOGY SA reported Profit Loss From Continuing Operations of -EUR 56.40 million for the 12-month period ending 2017-12-31, per its 20-F filed 2018-04-06.
Discontinued › Notes
ifrs-full:ProfitLossFromContinuingOperations · last filed 2018-04-06
| Period end | Profit Loss From Continuing Operations 12 month |
|---|---|
| 2017-12-31 | -56.40M EUR 20-F · filed 2018-04-06 |
| 2016-12-31 | -23.61M EUR 20-F · filed 2018-04-06 |
| 2015-12-31 | -29.11M EUR 20-F · filed 2018-04-06 |